Science

The future of cancer care lies in effectively diagnosing the disease, determining personalized therapies and monitoring and adjusting treatments in real time.

While defining and implementing individualized therapies for cancer patients is still in its infancy, the time has come to take advantage of emerging scientific advances to help save lives.

On-Q-ity's proprietary technologies prepare us to provide more frequent and effective monitoring of cancer progression by proactively measuring tumor biology and intelligently adjusting therapy as necessary throughout a patient's treatment lifecycle. Combining our DNA repair biomarkers with our ability to capture and analyze circulating tumor cells (CTCs) provides a complete view of an individual patient's pending treatment options and allows for more patient-friendly monitoring of the treatment's progress.

Our technologies originated from several highly regarded institutes: the Dana-Farber Cancer Institute, the Massachusetts Institute of Technology and Massachusetts General Hospital. On-Q-ity has assembled a team of expert scientific advisors from many leading cancer research and clinical practice centers worldwide.

By partnering with oncologists and some of the foremost experts in cancer diagnostics today, we can deliver the most comprehensive and personalized cancer care available to patients.